Lionheart Health, Inc.
About Lionheart Health, Inc.
Lionheart Health, Inc. is a biotechnology and medical device company that develops bioelectric stimulation platforms and provides longevity, wellness, and regenerative medicine services through a network of licensed clinics. It develops miniaturized, battery-free bioelectric implants that trigger the body’s own repair systems, stimulating protein production, guiding stem cells, growing blood vessels, and reducing inflammation. The company targets organ regeneration for the heart, kidneys, brain, and more, with a vision of a total body regeneration system. It is an official entrant in the XPRIZE Healthspan Longevity competition and won the Abbvie Allergan Aesthetics ULP Award for Innovation in Medical Aesthetics in December 2023.
- 🔗 Lionheart Health, Inc. Valuation & Funding History | Caplight
- 🔗 LionHeart Innovations - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 2023 Goals - Leonhardt Ventures
- 🔗 Lionheart Ventures Company Overview, Contact Details & Competitors | LeadIQ
- 🔗 Howard Leonhardt - Executive Chairman & CEO at ...
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Completed $387,500 private placement in May 2024.
- Total funding of $3M with $50M estimated valuation.
- Develops bioelectric implants for organ regeneration including KidneyCell and BladderCell.
- Planning global network of 124 Lionheart Longevity & Wellness clinics.
- Over 600,000 patients treated with related Leonhardt inventions to date.
Ask StreetZero about Lionheart Health, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account